⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for Study of Efficacy and Safety of Tisagenlecleucel in HR B-ALL EOC MRD Positive Patients

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Trial Identification

Brief Title: Study of Efficacy and Safety of Tisagenlecleucel in HR B-ALL EOC MRD Positive Patients

Official Title: A Phase II Trial of Tisagenlecleucel in First-line High-risk (HR) Pediatric and Young Adult Patients With B-cell Acute Lymphoblastic Leukemia (B-ALL) Who Are Minimal Residual Disease (MRD) Positive at the End of Consolidation (EOC) Therapy

Study ID: NCT03876769

Interventions

CTL019

Study Description

Brief Summary: This is a single arm, open-label, multi-center, phase II study to determine the efficacy and safety of tisagenlecleucel in de novo HR pediatric and young adult B-ALL patients who received first-line treatment and are EOC MRD positive. The study will have the following sequential phases: screening, pre-treatment, treatment \& follow-up, and survival. After tisagenlecleucel infusion, patient will have assessments performed more frequently in the first month and then at Day 29, then every 3 months for the first year, every 6 months for the second year, then yearly until the end of the study. Efficacy and safety will be assessed at study visits and as clinically indicated throughout the study. The study is expected to end in approximately 8 years after first patient first treatment (FPFT). A post-study long term follow-up safety will continue under a separate protocol per health authority guidelines.

Detailed Description:

Eligibility

Minimum Age: 1 Year

Eligible Ages: CHILD, ADULT

Sex: ALL

Healthy Volunteers: No

Locations

Children s Hospital of Alabama, Birmingham, Alabama, United States

Phoenix Children's Hospital, Phoenix, Arizona, United States

City of Hope National Medical, Duarte, California, United States

Childrens Hospital Los Angeles SC CTL019, Los Angeles, California, United States

Mattel Childrens Hospital UCLA, Los Angeles, California, United States

Childrens Hospital of Orange County CHOC Childrens, Orange, California, United States

Rady Children s Hospital CTBM100C2401, San Diego, California, United States

UCSF Medical Center ., San Francisco, California, United States

Stanford University Medical Center ., Stanford, California, United States

Childrens Hospital Colorado ., Aurora, Colorado, United States

Yale School of Medicine, New Haven, Connecticut, United States

Childrens National Hospital, Washington, District of Columbia, United States

Johns Hopkins All Childrens, Saint Petersburg, Florida, United States

Children's Healthcare of Atlanta Emory University IRB, Atlanta, Georgia, United States

Ann and Robert H Lurie Childrens Hospital of Chicago ., Chicago, Illinois, United States

University of Chicago Hospital ., Chicago, Illinois, United States

James Whitcomb Riley Hospital for Children, Indianapolis, Indiana, United States

Norton Children s Hospital, Louisville, Kentucky, United States

Johns Hopkins Oncology Center Cancer Research Building, Baltimore, Maryland, United States

Dana Farber Cancer Institute Dept.of DFCI, Boston, Massachusetts, United States

University of Michigan, Ann Arbor, Michigan, United States

University of Minnesota CAEB071B2201, Minneapolis, Minnesota, United States

University of Mississippi Medical Center Childrens Hospital ., Jackson, Mississippi, United States

Children s Mercy Hospital, Kansas City, Missouri, United States

St. Louis University/Cardinal Glennon Children's Hospital, Saint Louis, Missouri, United States

Washington Univ School of Medicine CTBM100C2412, Saint Louis, Missouri, United States

University of Nebraska Medical Center, Omaha, Nebraska, United States

Hackensack Univ Medical Center, Hackensack, New Jersey, United States

Roswell Park Cancer Institute Main Centre, Buffalo, New York, United States

Cohen Children's Medical Center of New York, New Hyde Park, New York, United States

Memorial Sloan Kettering Cancer Ctr ., New York, New York, United States

Columbia University Medical Center Oncology, New York, New York, United States

Duke University Medical Center ., Durham, North Carolina, United States

Cinn Children Hosp Medical Center, Cincinnati, Ohio, United States

Univ Hospital - Cleveland/Rainbow Babies and Children's Hosp Pediatric Nephrology, Cleveland, Ohio, United States

Cleveland Clinic Foundation Main Centre, Cleveland, Ohio, United States

Nationwide Childrens Hospital suite T6B, Columbus, Ohio, United States

Oregon Health and Science University ., Portland, Oregon, United States

Penn State Childrens Hospital, Hershey, Pennsylvania, United States

The Childrens Hosp of Philadelphia Div Gastroint Hepat and Nutr, Philadelphia, Pennsylvania, United States

Medical Uni of South Carolina Medical Univ of SC, Charleston, South Carolina, United States

Monroe Carell Jr Childrens Hospital at Vanderbilt, Nashville, Tennessee, United States

Univ of Texas Southwest Med Center, Dallas, Texas, United States

Texas Children's Cancer and Hematology Center, Houston, Texas, United States

Methodist Children's Hospital ., San Antonio, Texas, United States

University of Utah Clinical Trials Office ., Salt Lake City, Utah, United States

Children's Hospital of Richmond at VCU Pediatric Hematology Oncology, Richmond, Virginia, United States

University of Wisconsin Hospital and Clinics Pharmacy/Drug Shipping Address, Madison, Wisconsin, United States

Childrens Hospital of Wisconsin, Milwaukee, Wisconsin, United States

Novartis Investigative Site, Gent, , Belgium

Novartis Investigative Site, Gent, , Belgium

Novartis Investigative Site, Calgary, Alberta, Canada

Novartis Investigative Site, Toronto, Ontario, Canada

Novartis Investigative Site, Montreal, Quebec, Canada

Novartis Investigative Site, Copenhagen, , Denmark

Novartis Investigative Site, Helsinki, , Finland

Novartis Investigative Site, Paris, , France

Novartis Investigative Site, Frankfurt, , Germany

Novartis Investigative Site, Hamburg, , Germany

Novartis Investigative Site, Muenchen, , Germany

Novartis Investigative Site, Monza, MB, Italy

Novartis Investigative Site, Roma, RM, Italy

Prinses Maxima Centrum voor Kinderoncologie, Utrecht, CS, Netherlands

Novartis Investigative Site, Oslo, , Norway

Novartis Investigative Site, Esplugues De Llobregat, Barcelona, Spain

Novartis Investigative Site, Goteborg, , Sweden

Novartis Investigative Site, Stockholm, , Sweden

Novartis Investigative Site, London, , United Kingdom

Novartis Investigative Site, London, , United Kingdom

Contact Details

Name: Novartis Pharmaceuticals

Affiliation: Novartis Pharmaceuticals

Role: STUDY_DIRECTOR

Useful links and downloads for this trial

Clinicaltrials.gov

Google Search Results

Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: